no statement of use filed
on 13 Jul 2020
Last Applicant/ Owned by
Lilly Corporate Center
Indianapolis
IN
46285
Serial Number
87240320 filed on 17th Nov 2016
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolicRead More
Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, dementia, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, sleep disorders; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
No 87240320
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 13th Jul 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 13th Jul 2020 | ABANDONMENT - NO USE STATEMENT FILED |
| 28th Nov 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 27th Nov 2019 | EXTENSION 5 GRANTED |
| 22nd Nov 2019 | TEAS EXTENSION RECEIVED |
| 22nd Nov 2019 | EXTENSION 5 FILED |
| 19th Nov 2019 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| 18th Nov 2019 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| 11th May 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 09th May 2019 | EXTENSION 4 GRANTED |
